EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies

Julia Khinchin, Ani Rakoubian, Valentina Romano, Thomas Ryan, Johnathan Yarbro, Satoru Kobayashi, Qiangrong Liang

Frontiers in Pharmacology · 02.02.2026 · 17

DOI: 10.3389/fphar.2026.1681783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 02.02.2026. Verfasst von Julia Khinchin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY, United States. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metformin, a cornerstone therapy for type 2 diabetes mellitus, has emerged as a promising cardioprotective agent with effects that extend well beyond glycemic control. This review synthesizes current evidence on the molecular and cellular mechanisms underlying metformin’s glycemic control and cardiovascular benefits, highlighting both AMPK-dependent and AMPK-independent pathways. We examine its modulation of mitochondrial function, oxidative stress, inflammation, autophagy, and apoptosis across major cardiac conditions, including ischemia/reperfusion injury, heart failure, diabetic cardiomyopathy, and anthracycline-induced cardiotoxicity. By integrating evidence from both preclinical and clinical studies, we evaluate the translational potential of metformin’s pleiotropic actions across specific cardiac pathologies and outline key directions for future research and therapeutic innovation. Together, these insights highlight metformin’s promise in reshaping cardiovascular care beyond its traditional role in diabetes management.

Schlagwörter

Stichwörter der Autor:innen

AMPKanthracycline cardiotoxicityautophagycardioprotectiondiabetic cardiomyopathyheart failureischemia-reperfusion injurymetformin

Autor:innen und Institutionen

  • Department of Biomedical Sciences, New York Institute of Technology, College of Osteopathic Medicine, Old Westbury, NY, United States.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Khinchin, J., Rakoubian, A., Romano, V., Ryan, T., Yarbro, J., Kobayashi, S., & Liang, Q. (2026). Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1681783

Vancouver

Khinchin J, Rakoubian A, Romano V, Ryan T, Yarbro J, Kobayashi S, et al. Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1681783

BibTeX
@article{Khinchin2026,
  author = {Khinchin, Julia and Rakoubian, Ani and Romano, Valentina and Ryan, Thomas and Yarbro, Johnathan and Kobayashi, Satoru and Liang, Qiangrong},
  title = {Repurposing metformin for cardioprotection: mechanisms and therapeutic potential across cardiovascular pathologies},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1681783}
}
Kostenlos starten →